Functional Intact Fibrinogen (FiF) test superior to Clauss for cardiovascular risk :
This article was originally published in Clinica
American Biogenetic Sciences' Functional Intact Fibrinogen test is an accurate means of assessing risk in cardiovascular disease patients, say Framingham Heart study researchers. The test, which measures elevated fibrinogen levels in the blood, showed a closer correlation with cardiovascular disease than the commonly-used Clauss method, says ABS. The company hopes to file for 510(k) clearance later this year and expects to see fibrinogen testing incorporated into routine practice in the future.
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.